These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23488303)

  • 1. [Statement of the Polish Gynecological Society Expert Group on the use of Macmiror Complex 500].
    Polish Gynecological Society Expert Group
    Ginekol Pol; 2012 Dec; 83(12):956-9. PubMed ID: 23488303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The treatment of vaginal infections with Macmiror and Macmiror Complex].
    Zlatkov V; Karag'ozov I
    Akush Ginekol (Sofiia); 1998; 37(2):57-9. PubMed ID: 9859542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ["Mixed" and "miscellaneous" vulvovaginitis: diagnostics and therapy of vaginal administration of nystatin and nifuratel].
    Cepický P; Malina J; Líbalová Z; Kuzelová M
    Ceska Gynekol; 2005 May; 70(3):232-7. PubMed ID: 16047929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A multicenter study of the antimicrobial effect of Macmiror and Macmiror Complex in the treatment of vaginal infections].
    Karag'ozov I; Shopova E; Poriazov K; Abaliev I; Kozovski I; Ianeva R; Drenska S; Vasileva P; Bozhinova S; Popov I; Stoĭkov S
    Akush Ginekol (Sofiia); 1999; 38(3):61-2. PubMed ID: 10734688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Macmiror, Macmiror Complex--combined antimicrobial preparation for the treatment of vulvo-vaginal infection].
    Akush Ginekol (Sofiia); 2008; 47(2):55. PubMed ID: 18642589
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical study on the dose-effect relationship of a nifuratel-nystatin combination in the treatment of vulvo-vaginal infections.
    Polatti F; Nappi RE; Brundu B; Fantuzzi M; Frisenda L
    Arzneimittelforschung; 2003; 53(10):730-7. PubMed ID: 14650366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nifuratel and nystatin combination therapy in vulvovaginitis of mixed etiology in children and adolescents].
    Horejsí J; Uhrová E; Stucbartová M
    Ceska Gynekol; 1996 Feb; 61(1):51-3. PubMed ID: 8624598
    [No Abstract]   [Full Text] [Related]  

  • 8. [Statement of the Polish Gynecological Society expert panel concerning application of Fluomizin].
    Polish Gynecological Society
    Ginekol Pol; 2013 Mar; 84(3):237-9. PubMed ID: 23700855
    [No Abstract]   [Full Text] [Related]  

  • 9. [Local combined therapy of vaginal infections by nifuratel-nistatin].
    Jahić M; Balić A; Nurkić M; Dragović J; Adzajlić A; Habibović A; Mesalić L; Zigić A
    Med Glas (Zenica); 2010 Feb; 7(1):86-8. PubMed ID: 20387731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effects of nifuratel in vulvovaginal infections. A meta-analysis of metronidazole-controlled trials.
    Mendling W; Poli A; Magnani P
    Arzneimittelforschung; 2002; 52(10):725-30. PubMed ID: 12442634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Statement of the Polish Gynecological Society Expert Group on the vitamin and microelement selective supplementation in pregnant women concerning dietary supplements Selecta Pregna 1 and Selecta Pregna 2].
    Polish Gynecological Society
    Ginekol Pol; 2013 Sep; 84(9):815-8. PubMed ID: 24191523
    [No Abstract]   [Full Text] [Related]  

  • 12. [Statement of the Polish Gynecological Society Expert Group on the use of ellen probiotic tampon].
    Zespoł Ekspertów Polskiego Towarzystwa Ginekologicznego
    Ginekol Pol; 2012 Aug; 83(8):633-8. PubMed ID: 23342891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Microbiological evaluation of the effectiveness of gynalgin in the treatment of vaginitis].
    Sikorski R; Hencner Z; Gliński Z; Wawrzkiewicz K; Radomański T; Milart P; Paszkowski T; Skrzypczak W; Sławiński P; Maruszak E
    Wiad Lek; 1992 Apr; 45(7-8):263-9. PubMed ID: 1462586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiological and pharmaco-toxicological profile of nifuratel and its favourable risk/benefit ratio for the treatment of vulvo-vaginal infections. A review.
    Mendling W; Mailland F
    Arzneimittelforschung; 2002; 52(1):8-13. PubMed ID: 11838277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multipurpose treatment of vaginal infections].
    Nikolov A; Masseva A; Shopova E; Georgiev S
    Akush Ginekol (Sofiia); 2012; 51(5):10-4. PubMed ID: 23234030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recommendations of the Polish Gynecological Society concerning application of cardiotocography in obstetrics].
    Polish Gynecological Society
    Ginekol Pol; 2014 Sep; 85(9):713-6. PubMed ID: 25322546
    [No Abstract]   [Full Text] [Related]  

  • 17. [Polish Gynecological Society and Polish Society for Reproductive Medicine recommendations for the diagnosis and treatment of infertility].
    Kuczyński W; Kurzawa R; Oszukowski P; Pawelczyk L; Poreba R; Radowicki S; Szamatowicz M; Wołczyński S;
    Ginekol Pol; 2012 Feb; 83(2):149-54. PubMed ID: 22568363
    [No Abstract]   [Full Text] [Related]  

  • 18. [Polish Gynecological Society Expert Committee recommendations regarding application of Chela-Mag B6 Mama in obstetrics and gynecology].
    Polish Gynecological Society
    Ginekol Pol; 2011 Oct; 82(10):792-4. PubMed ID: 22379946
    [No Abstract]   [Full Text] [Related]  

  • 19. High-dose nifuratel for simple and mixed aerobic vaginitis: A single-center prospective open-label cohort study.
    Liang Q; Li N; Song S; Zhang A; Li N; Duan Y
    J Obstet Gynaecol Res; 2016 Oct; 42(10):1354-1360. PubMed ID: 27435791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The statement of Polish Gynecological Society Experts on the importance of good hydration for the prevention of diseases in women of reproductive age].
    Polish Gynecological Society Experts
    Ginekol Pol; 2011 Dec; 82(12):943-5. PubMed ID: 22384633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.